tiprankstipranks
Trending News
More News >
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market

Integrated BioPharma (INBP) Financial Statements

Compare
8 Followers

Integrated BioPharma Financial Overview

Integrated BioPharma's market cap is currently $11.38M. The company's EPS TTM is $0.004; its P/E ratio is 17.26; Integrated BioPharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 54.35M$ 50.32M$ 50.67M$ 56.25M$ 63.56M
Gross Profit$ 5.56M$ 3.88M$ 4.06M$ 6.55M$ 9.48M
Operating Income$ 2.02M$ 251.00K$ 120.00K$ 1.97M$ 5.78M
EBITDA$ 3.38M$ 1.47M$ 1.27M$ 3.56M$ 6.61M
Net Income$ 808.00K$ 112.00K$ -34.00K$ 3.84M$ 8.01M
Balance Sheet
Cash & Short-Term Investments$ 3.62M$ 1.68M$ 1.32M$ 331.00K$ 210.00K
Total Assets$ 24.90M$ 26.21M$ 25.43M$ 25.25M$ 25.44M
Total Debt$ 1.01M$ 1.80M$ 2.67M$ 2.06M$ 4.33M
Net Debt$ -2.60M$ 121.00K$ 1.36M$ 1.72M$ 4.12M
Total Liabilities$ 4.58M$ 6.97M$ 6.57M$ 6.67M$ 11.11M
Stockholders' Equity$ 20.32M$ 19.24M$ 18.86M$ 18.57M$ 14.33M
Cash Flow
Free Cash Flow$ 1.87M$ 390.00K$ 1.12M$ 3.60M$ 2.75M
Operating Cash Flow$ 2.06M$ 943.00K$ 1.23M$ 4.09M$ 3.05M
Investing Cash Flow$ -205.00K$ -553.00K$ -111.00K$ -465.00K$ -199.00K
Financing Cash Flow$ 78.00K$ -29.00K$ -136.00K$ -3.50M$ -3.04M
Currency in USD

Integrated BioPharma Earnings and Revenue History

Integrated BioPharma Debt to Assets

Integrated BioPharma Cash Flow

Integrated BioPharma Forecast EPS vs Actual EPS